These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 28753176)

  • 1. Cystic Fibrosis-related Liver Disease: Research Challenges and Future Perspectives.
    Debray D; Narkewicz MR; Bodewes FAJA; Colombo C; Housset C; de Jonge HR; Jonker JW; Kelly DA; Ling SC; Poynard T; Sogni P; Trauner M; Witters P; Baumann U; Wilschanski M; Verkade HJ
    J Pediatr Gastroenterol Nutr; 2017 Oct; 65(4):443-448. PubMed ID: 28753176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis, follow-up and treatment of cystic fibrosis-related liver disease.
    van de Peppel IP; Bertolini A; Jonker JW; Bodewes FAJA; Verkade HJ
    Curr Opin Pulm Med; 2017 Nov; 23(6):562-569. PubMed ID: 28837442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic fibrosis related liver disease--another black box in hepatology.
    Staufer K; Halilbasic E; Trauner M; Kazemi-Shirazi L
    Int J Mol Sci; 2014 Aug; 15(8):13529-49. PubMed ID: 25093717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Treatment Options for Cystic Fibrosis-Related Liver Disease.
    Staufer K
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver disease in patients with cystic fibrosis.
    Kamal N; Surana P; Koh C
    Curr Opin Gastroenterol; 2018 May; 34(3):146-151. PubMed ID: 29438119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards a Standardized Classification of the Hepatobiliary Manifestations in Cystic Fibrosis (CFHBI): A Joint ESPGHAN/NASPGHAN Position Paper.
    Bodewes FAJA; Freeman AJ; Weymann A; Debray D; Scheers I; Verkade HJ; Narkewicz MR
    J Pediatr Gastroenterol Nutr; 2024 Jan; 78(1):153-165. PubMed ID: 38291686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic Manifestations of Cystic Fibrosis.
    Sakiani S; Kleiner DE; Heller T; Koh C
    Clin Liver Dis; 2019 May; 23(2):263-277. PubMed ID: 30947876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver disease in cystic fibrosis.
    Leeuwen L; Fitzgerald DA; Gaskin KJ
    Paediatr Respir Rev; 2014 Mar; 15(1):69-74. PubMed ID: 23769887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal, Pancreatic, and Hepatobiliary Manifestations of Cystic Fibrosis.
    Sathe MN; Freeman AJ
    Pediatr Clin North Am; 2016 Aug; 63(4):679-98. PubMed ID: 27469182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: epidemiology, pathogenesis and management of liver disease in adults with cystic fibrosis.
    Scott J; Jones AM; Piper Hanley K; Athwal VS
    Aliment Pharmacol Ther; 2022 Feb; 55(4):389-400. PubMed ID: 35048397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous liver-pancreas transplantation for cystic fibrosis-related liver disease: a multicenter experience.
    Bandsma RH; Bozic MA; Fridell JA; Crull MH; Molleston J; Avitzur Y; Mozer-Glassberg Y; Gonzalez-Peralta RP; Hodik M; Fecteau A; de Angelis M; Durie P; Ng VL
    J Cyst Fibros; 2014 Jul; 13(4):471-7. PubMed ID: 24440180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver disease in cystic fibrosis.
    Rowland M; Bourke B
    Curr Opin Pulm Med; 2011 Nov; 17(6):461-6. PubMed ID: 21881510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging clinical perspectives in cystic fibrosis liver disease.
    Athwal VS; Scott JA; Fitzpatrick E; Rowland M
    Curr Opin Pulm Med; 2021 Nov; 27(6):593-599. PubMed ID: 34482340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natural history of cystic fibrosis liver disease a prospective cohort study.
    Rowland M; Drummond J; Connolly L; Daly E; McCormick PA; Bourke B; ;
    J Cyst Fibros; 2023 Nov; 22(6):1054-1061. PubMed ID: 37495468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome in cystic fibrosis liver disease.
    Rowland M; Gallagher CG; O'Laoide R; Canny G; Broderick A; Hayes R; Greally P; Slattery D; Daly L; Durie P; Bourke B
    Am J Gastroenterol; 2011 Jan; 106(1):104-9. PubMed ID: 20736939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver disease in adult patients with cystic fibrosis: a frequent and independent prognostic factor associated with death or lung transplantation.
    Chryssostalis A; Hubert D; Coste J; Kanaan R; Burgel PR; Desmazes-Dufeu N; Soubrane O; Dusser D; Sogni P
    J Hepatol; 2011 Dec; 55(6):1377-82. PubMed ID: 21703187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis.
    Smith JL; Lewindon PJ; Hoskins AC; Pereira TN; Setchell KD; O'Connell NC; Shepherd RW; Ramm GA
    Hepatology; 2004 Jun; 39(6):1673-82. PubMed ID: 15185309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barrier to using APRI and GPR as identifiers of cystic fibrosis liver disease.
    Sellers ZM
    J Cyst Fibros; 2021 May; 20(3):551. PubMed ID: 32747194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating microRNAs as noninvasive diagnostic biomarkers of liver disease in children with cystic fibrosis.
    Cook NL; Pereira TN; Lewindon PJ; Shepherd RW; Ramm GA
    J Pediatr Gastroenterol Nutr; 2015 Feb; 60(2):247-54. PubMed ID: 25625579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver disease.
    Rath T; Hage L; Kügler M; Menendez Menendez K; Zachoval R; Naehrlich L; Schulz R; Roderfeld M; Roeb E
    PLoS One; 2013; 8(3):e58955. PubMed ID: 23516586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.